Kava Haven

product on market Liquid Kava Haven 🟢 Safety: 90/100
Brand: Kava Haven
🟢 90/100

This product looks safe

  • Noble Kava: 500mg is 2.0× the Tolerable Upper Intake Level (250mg)
  • 25% of ingredients have research evidence
C Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →
📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Noble Kava: 500mg is 2.0× the Tolerable Upper Intake Level (250mg)

Label Data

1.5 fl. Oz. Serving Size
17 Servings
Botanical Product Type
25% Evidence Coverage

Supplement Facts — Evidence Check

Calories
30 Calorie(s)
Total Carbohydrates
5 Gram(s) (2% DV)
Total Sugars
5 Gram(s)
500 mg
⚠️ Exceeds Tolerable Upper Intake Level by 2.0× (UL: 250 mg) 📚 12 studies (Tier A: 0, B: 5)
This product: 500mg UL 250mg

Other Ingredients

Water, Filtered Lemon Juice Concentrate White Grape Juice Lemon Extract Cardamom Extract Orange Blossom Extract Vanilla Extract Ginger Extract Natural Flavors Potassium Sorbate Sodium Benzoate

Label Claims — Verification

❓ All Other
All Other (99% of products) Structure/Function (74% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

🧪 Formulation Notes

Zero proof Kava-infused non-alcoholic spirit

Kava-infused non-alcoholic spirit

Product Details

DSLD Entry Date 2025-08-22
Product Type Botanical
Form Liquid
Brand Kava Haven
DSLD ID 332977
Data Updated 2026-04-11

Research Evidence

19 Research Sources
48 Avg Quality Score
8 Rct
5 Systematic Review
4 Meta Analysis
2 Clinical Trial
B Kava extract for treating anxiety
Meta Analysis The Cochrane database of systematic reviews 2003
PubMed Cochrane
B Kava for Generalized Anxiety Disorder: A Review of Current Evidence
Meta Analysis Journal of alternative and complementary medicine (New York, N.Y.) 2018
PubMed DOI
B Kava extract for treating anxiety
Systematic Review The Cochrane database of systematic reviews 2001
PubMed Cochrane
B Kava extract for treating anxiety
Systematic Review The Cochrane database of systematic reviews 2002
PubMed Cochrane
B The effectiveness and safety of Kava Kava for treating anxiety symptoms: A systematic review and analysis of randomized clinical trials
Systematic Review Complementary therapies in clinical practice 2018
PubMed DOI
C Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study
Rct The Australian and New Zealand journal of psychiatry 2020
PubMed DOI
C Kava and St. John's Wort: current evidence for use in mood and anxiety disorders
Systematic Review Journal of alternative and complementary medicine (New York, N.Y.) 2009
PubMed DOI
C Neuroimaging Insights: Kava's (Piper methysticum) Effect on Dorsal Anterior Cingulate Cortex GABA in Generalized Anxiety Disorder.
Rct Nutrients
PubMed DOI
C The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
Meta Analysis Annals of internal medicine 2002
PubMed
C Efficacy of kava extract for treating anxiety: systematic review and meta-analysis
Meta Analysis Journal of clinical psychopharmacology 2000
PubMed
View all evidence for Kava →

Compare Similar Products

Kava Source Naturals 100
Kava Source Naturals 100
Kava Herbalist & Alchemist 100
Kava Root Extra Strength Gaia Herbs 100
Kava Root Extra Strength Gaia Herbs 100
View all Kava products →
Kava research & evidence Best Kava rankings All Kava products More from Kava Haven View on NIH DSLD →